Literature DB >> 758993

Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation.

J F Spear, L N Horowitz, A B Hodess, H MacVaugh, E N Moore.   

Abstract

Ventricular tissues were obtained at the time of operation from 12 patients who underwent aneurysmectomy or mitral valve replacement. The electrophysiologic characteristics of these tissues were determined in a tissue bath using microelectrodes. Normal-appearing action potentials were recorded from surviving Purkinje fibers and ventricular muscle cells within infarcted ventricular tissues. Normal muscle action potential recordings from infarcted tissues were similar to action potentials from noninfarcted papillary muscles, except that the duration of the action potential was significantly longer in the former. In other areas slow response potentials were recorded. These action potentials conducted slowly and were eliminated by verapamil. We observed verapamil-sensitive slow response automaticity, but this did not correlate with ventricular tachycardias, present in three patients. Variable amplitude responses arising from normal resting potentials and characterized by stimulus intensity-dependent changes in action potential amplitude were recorded in tissues from two patients. These potentials had many characteristics similar to the slow response, but were not eliminated by verapamil. We also saw inexcitable cells with both normal and abnormal resting potentials. The heterogeneous electrophysiologic characteristics of these tissues provide a likely substrate for arrhythmias and may be the source of the ectopic ventricular rhythms observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758993     DOI: 10.1161/01.cir.59.2.247

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

Authors:  W Schmitz
Journal:  Klin Wochenschr       Date:  1980-09-15

2.  Medical staff conference. Treatment of cardiac arrhythmias.

Authors: 
Journal:  West J Med       Date:  1979-12

3.  Recent trends in the management of life-threatening ventricular arrhythmias.

Authors:  B N Singh; J N Weiss; K Nademanee; J H Wittig; P Guzy
Journal:  West J Med       Date:  1984-11

4.  Response of recurrent sustained ventricular tachycardia to verapamil.

Authors:  B Belhassen; H H Rotmensch; S Laniado
Journal:  Br Heart J       Date:  1981-12

5.  Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.

Authors:  Y Aizawa; M Chinushi; H Kitazawa; T Washizuka; A Abe; A Shibata; I Kodama
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

Review 6.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

7.  Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.

Authors:  R J Sung; W A Shapiro; E N Shen; F Morady; J Davis
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  H V Huikuri; M J Koistinen; K E Airaksinen; M J Ikäheimo
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 9.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

10.  Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.

Authors:  R J Sung; E C Keung; N X Nguyen; E C Huycke
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.